Table 2.

Recurrence rates (stage I–III breast cancers)

	Trastuzumab	Luminal B (n = 259) N (%)	HER2 (n = 164) N (%)
Total Recurrence: n (%)	No	36/94 (38.3)	22/60 (36.7)
	Yes	14/165 (8.5)	19/104 (18.3)
		p < 0.001	p = 0.009
LRR: n (%)	No	15/94 (16)	10/60 (16.7)
	Yes	3/165 (1.8)	11/104 (10.6)
		p < 0.001	p = 0.261
Distant: n (%)	No	34/94(36.2)	19/60 (31.7)
	Yes	11/165(6.7)	13/104 (12.5)
		p < 0.001	p = 0.003

Bold values indicate significant p value

LRR Local Regional Recurrence, Distant distant metastasis